AFP and hepatocellular carcinoma: Angiopoietin-2 (ANG2), associated with tumor angiogenesis (Tanaka et al. 1999, 2002), has been shown to outperform AFP in predicting overall survival (OS) in HCC (Llovet et al. 2012).